Sharon Bio-Medicine Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 22	Mar ' 20	Mar ' 18	Mar ' 17	Mar ' 16

Sources of funds

Owner's fund

Equity share capital

1.15

23.79

23.79

23.79

23.79

Share application money

-

-

-

-

13.72

Preference share capital

-

-

-

-

-

Reserves & surplus

-610.37

-663.54

-659.02

-558.02

-219.00

Loan funds

Secured loans

827.32

827.32

632.48

727.19

649.73

Unsecured loans

-

-

-

-

186.59

Total

218.10

187.57

-2.75

192.96

654.83

Uses of funds

Fixed assets

Gross block

134.79

148.68

185.27

291.08

408.15

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

-

-

-

-

89.60

Net block

134.79

148.68

185.27

291.08

318.56

Capital work-in-progress

-

-

-

-

-

Investments

-

-

-

-

0.06

Net current assets

Current assets, loans & advances

164.34

127.64

65.89

62.51

404.22

Less : current liabilities & provisions

81.03

88.75

253.91

160.63

68.01

Total net current assets

83.31

38.89

-188.02

-98.12

336.21

Miscellaneous expenses not written

-

-

-

-

-

Total

218.10

187.57

-2.75

192.96

654.83

Notes:

Book value of unquoted investments

-

-

-

-

0.06

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

0.01

Number of equity sharesoutstanding (Lacs)

57.56

1189.36

1189.36

1189.36

1189.36